Product Information

RIVASTIGMINE 4.6 MG/24HR PATCH is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $1.8155 per EA under NDC 70710119607. Its NADAC has been published 365 times since Aug 28, 2019.

FDA first approved this application on Mar 4, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIVASTIGMINE 4.6 MG/24HR PATCH

Rivastigmine
$1.8155per EA

Strength

4.6 mg/24h

NDC

70710119607

Classification

Generic

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Effective Date

8/19/2026

Active Ingredients

RIVASTIGMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA206318

FDA Approved

3/4/2019

TE Code

AB

On Market Since

3/6/2019

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for RIVASTIGMINE 4.6 MG/24HR PATCH has been published 365 times since Aug 28, 2019, and over the history we have for it it has declined 59.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.8155 per EA
All-time high$4.5234 (Nov 13, 2019)
All-time low$1.4682 (Nov 20, 2024)
52-week high$1.8816
52-week low$1.7654
Median price$2.1235
Average price$2.5552
Largest weekly change+42.4% (May 19, 2021)
Weeks tracked365
Tracking sinceAug 28, 2019

Price History

1W

+1.3%

1M

+1.3%

3M

+0.1%

6M

-2.6%

1Y

-1.2%

3Y

-4.4%

5Y

-49.7%

All

-59.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RIVASTIGMINE 4.6 MG/24HR PATCH?

The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 4.6 MG/24HR PATCH, manufactured by Zydus Pharmaceuticals (USA) Inc., is $1.8155 per EA (NDC 70710119607), effective Aug 19, 2026.

How has the price of RIVASTIGMINE 4.6 MG/24HR PATCH changed over time?

Over the history we have for it, the NADAC for RIVASTIGMINE 4.6 MG/24HR PATCH has declined 59.2%. It has been tracked across 365 weekly CMS publications since Aug 28, 2019.

What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 4.6 MG/24HR PATCH?

Since Aug 28, 2019, the NADAC for RIVASTIGMINE 4.6 MG/24HR PATCH has ranged from a low of $1.4682 (Nov 20, 2024) to a high of $4.5234 (Nov 13, 2019), with a median of $2.1235 per EA.

Are there cheaper alternatives to RIVASTIGMINE 4.6 MG/24HR PATCH?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIVASTIGMINE 4.6 MG/24HR PATCH in a comparable dosage form, but none are currently priced below it.

Who manufactures RIVASTIGMINE 4.6 MG/24HR PATCH?

RIVASTIGMINE 4.6 MG/24HR PATCH (NDC 70710119607) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.